Aptose Biosciences Inc. — Contributions, Lobbying & Contracts | Poliscope

Aptose Biosciences Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

APTOF

organization

SIC: 2836

Also known as: Aptose Biosciences Inc.

SEC Insider

$4.0M

151 transactions

Summary

Aptose Biosciences Inc. (APTOF) is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $984KSales: $2.9M16 insiders

Date	Insider	Type	Value
2023-09-22	Seizinger Bernd R.	Buy	$53K
2024-11-25	Rice William G.(Chair, President & CEO)	Buy	$20K
2024-11-25	Rice William G.(Chair, President & CEO)	Buy	—
2024-02-05	Whitehead Warren	A	$0
2024-02-05	BURGER DENIS R	A	$0
2024-02-05	Ashe Carol Gail	A	$0
2024-02-05	Vincent Mark D.	A	$0
2024-02-05	PLATZER ERICH	A	$0
2024-02-05	Seizinger Bernd R.	A	$0
2024-02-05	Rice William G.(Chair, President & CEO)	A	$0
2024-02-05	LEDRU PHILIPPE(Sr VP & Ch Commerical Officer)	A	$0
2024-02-05	Bejar Rafael(Sr VP & Chief Medical Officer)	A	$0
2024-02-05	Payne Fletcher(Sr VP and CFO)	A	$0
2023-01-19	Bejar Rafael(Sr. VP, Chief Medical Officer)	A	$0
2023-01-19	Bejar Rafael(Sr. VP, Chief Medical Officer)	A	$0
2023-01-19	Ashe Carol Gail	A	$0
2023-01-19	BURGER DENIS R	A	$0
2023-01-19	LEDRU PHILIPPE(Chief Commercial Officer)	A	$0
2023-01-19	LEDRU PHILIPPE(Chief Commercial Officer)	A	$0
2023-01-19	Payne Fletcher(SR VP & Chief Fin. Officer)	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR